Literature DB >> 2880125

Tardive myoclonus.

H Tominaga, H Fukuzako, K Izumi, T Koja, T Fukuda, H Fujii, K Matsumoto, H Sonoda, K Imamura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2880125     DOI： 10.1016/s0140-6736(87)92042-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Myoclonus associated with high doses of morphine.

Authors: 
Journal:  BMJ       Date:  1989-09-09

Review 2.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 3.  Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly.

Authors:  Carlos Estevez-Fraga; Paul Zeun; Jose Luis López-Sendón Moreno
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

Review 4.  Drug-induced myoclonus: frequency, mechanisms and management.

Authors:  Félix Javier Jiménez-Jiménez; Inmaculada Puertas; María de Toledo-Heras
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

5.  An update on tardive dyskinesia: from phenomenology to treatment.

Authors:  Olga Waln; Joseph Jankovic
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-07-12

Review 6.  The clinical heterogeneity of drug-induced myoclonus: an illustrated review.

Authors:  Sabine Janssen; Bastiaan R Bloem; Bart P van de Warrenburg
Journal:  J Neurol       Date:  2016-12-16       Impact factor: 4.849
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.